Neo-Green Herbs INC, the US subsidiary of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd. was founded in 2023, and has been adhering to the developing concept of the parent company, NGP, which has always stood strong in the face of inheriting and popularizing the millennial-long TCM culture with modern techniques.
We have served many regions around the world, including traditional Chinese medicine clinics, herbal extract wholesalers, medical institutions, and clinics. "We are committed to empowering global pharmacies through an efficient B2B supply chain to safeguard health."
The global landscape of chronic pain management is shifting. As the limitations and side effects of long-term NSAID use become more apparent, the world is turning toward Eastern Medicine for Arthritis. The market for TCM granules has seen a compound annual growth rate (CAGR) of over 12% in Western markets, driven by a demand for "clean label" botanical solutions and standardized modern delivery methods.
In the industrial sector, large-scale pharmaceutical buyers and healthcare networks are moving away from raw herbs toward concentrated granules. These offer precision dosing, high bioavailability, and excellent shelf stability, making them the preferred choice for modern clinical integration.
Clinical Grade Arthritis Management Formulas
View Product Details
High-Concentration Single Herb Extracts
Inquire for Bulk Pricing
Modern enterprises require more than just a supplier; they need a strategic partner. Our B2B infrastructure is optimized for global procurement needs, providing:
Founded in 2009, Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (NGP) is a comprehensive TCM enterprise integrating research and development, production and operation, especially in the field of TCM granules, which enjoys a high reputation.
As a "National Enterprise Technology Center", "High-tech Enterprise" and "National Key Leading Enterprise in Agricultural Industrialization", NGP is not only one of the six pilot manufacturers approved by China for the formulation and production of TCM granules, but also the only TCM granule enterprise in the southwestern region of China.
In the coming decade, China TCM granules will lead the market due to the standardization of "Daodi" medicinal materials and the implementation of AI-driven extraction processes. Large-scale Arthritis Manufacturers & Suppliers are now focusing on the molecular identification of herbal components to ensure consistent efficacy. For global medical institutions, the adoption of TCM granules represents a leap toward digitalized traditional medicine, allowing for automated pharmacy dispensing and personalized patient care protocols.
Neo-Green Herbs
